Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Glucotrack (GCTK) Other Working Capital Changes (2016 - 2020)

Glucotrack's Other Working Capital Changes history spans 7 years, with the latest figure at -$2000.0 for Q4 2020.

  • For the quarter ending Q4 2020, Other Working Capital Changes rose 56.2% year-over-year to -$2000.0, compared with a TTM value of $9000.0 through Dec 2020, down 52.63%, and an annual FY2025 reading of $133000.0, up 159.11% over the prior year.
  • Other Working Capital Changes for Q4 2020 was -$2000.0 at Glucotrack, up from -$25000.0 in the prior quarter.
  • The five-year high for Other Working Capital Changes was $75353.0 in Q3 2019, with the low at -$190590.0 in Q1 2017.
  • Average Other Working Capital Changes over 5 years is -$25271.3, with a median of -$9452.0 recorded in 2016.
  • Year-over-year, Other Working Capital Changes plummeted 45090.88% in 2016 and then soared 890.97% in 2019.
  • Tracing GCTK's Other Working Capital Changes over 5 years: stood at -$9452.0 in 2016, then plummeted by 215.67% to -$29837.0 in 2017, then plummeted by 221.38% to -$95889.0 in 2018, then surged by 95.24% to -$4566.0 in 2019, then skyrocketed by 56.2% to -$2000.0 in 2020.
  • Per Business Quant, the three most recent readings for GCTK's Other Working Capital Changes are -$2000.0 (Q4 2020), -$25000.0 (Q3 2020), and -$17000.0 (Q2 2020).